Rates and predictors of major bleeding events in patients with peripheral artery disease (PAD) treated with antiplatelet medications are not known. This post-hoc analysis of EUCLID aimed to (1) determine… Click to show full abstract
Rates and predictors of major bleeding events in patients with peripheral artery disease (PAD) treated with antiplatelet medications are not known. This post-hoc analysis of EUCLID aimed to (1) determine the incidence of minor/major bleeding; (2) determine the predictors of major bleeding; and (3)
               
Click one of the above tabs to view related content.